INSIGHTS ON CLINICAL TRIAL PARTNERING

• Clinical Leader Smart Sourcing Solutions Expo: Retention By Design

  Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.

• Start Your Journey With Block Clinical

  Achieve unprecedented transparency with a platform designed to help you plan, manage, and analyze patient and site support costs instantly and effortlessly.

• Transform Your Clinical Trials With Central eSource

  Accelerate your trial startup and reduce site burden with a central eSource that allows sponsors to develop and publish central source templates to sites.

• How Remote Pharmacy Monitoring Improves Trial Compliance

  Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  10/21/2025

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials

  5/9/2025

  Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

• Mergers And Acquisitions: How Institutional Knowledge Protecting Value

  5/27/2026

  M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

• Improving Clinical Trial Label Translation Through Centralized Reuse And Control

  8/10/2026

  Eliminate workflow inefficiencies and regulatory risk in global trials with a centralized translation framework and validated phrase library for consistent, cost-effective execution.

• Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments

  1/15/2025

  Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties